← Leaderboards
Joe G. N. Garcia
University Of Florida
$45,532,409
Attributed
$51,947,019
Total exposure
44
Grants
32
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.5M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$108,066,692 · 47
By mechanism
P01$61,720,203 · 16
R01$9,876,454 · 9
P50$8,970,764 · 3
R42$8,122,276 · 4
U01$7,133,756 · 4
R25$3,276,733 · 1
Top collaborators
- Francisco A Moreno9 shared
- Sairam Parthasarathy5 shared
- Ting Wang4 shared
- Laura L Koth3 shared
- Augustine M Choi2 shared
- Ivan O. Rosas2 shared
- Mohamed Ahmed1 shared
- Christian Bime1 shared
Most similar at University Of Florida
Same institution · by research overlap
- Andrew Justin Bryant$4,040,313
Others in their field
Top investigators on “Lung”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$372,040,227
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard K. Wilson · Washington University$201,818,043
- Walter John Curran · Thomas Jefferson University$112,093,071
Research focus
LungRegulationInflammatoryStructureInflammationBlood VesselsSeveritiesTherapeutic TargetEndothelial CellsResponseLung InjuryGenesProteinsGeneticPredispositionUniversitiesMolecularCellsDesignResearch PersonnelCytoskeletonBasePre-ClinicalMediating
Grant awards (153)
Cytoskeletal Regulation of Lung Endothelial Pathobiology in ARDS$2,185,600
P01 · FY2025 · HL · contact PI
Novel Involvement of eNAMPT/TLR4 Signaling in PAH Vascular Remodeling and Right Ventricular Dysfunction$965,998
R01 · FY2025 · HL · contact PI
Regulation of Peripheral EC Cytoskeletal Remodeling, Gap Closure and Barrier Restoration by nmMLCK/MYLK and Cortactin/CTTN$377,845
P01 · FY2025 · HL · contact PI
Role of Endothelial eNAMPT/NAMPT secretion and TLR4 signaling in the ARDS Vascular Endotype$299,983
P01 · FY2025 · HL · contact PI
Administrative Core$157,269
P01 · FY2025 · HL · contact PI
Cytoskeletal Regulation of Lung Endothelial Pathobiology in ARDS$2,141,888
P01 · FY2024 · HL · contact PI
Targeting the eNAMPT/TLR4 pathway to reduce Inflammatory Bowel Disease severity$975,215
R42 · FY2024 · DK · contact PI
A Randomized Phase 2A Clinical Trial Pioneering the Utility of an eNAMPT-Reducing Therapy in ARDS/VILI: the PUERTA Trial$957,594
R44 · FY2024 · HL · contact PI
Preclinical Development of a Novel eNAMPT-Neutralizing mAb for Pulmonary Hypertension$808,999
R42 · FY2024 · HL · contact PI
Regulation of Peripheral EC Cytoskeletal Remodeling, Gap Closure and Barrier Restoration by nmMLCK/MYLK and Cortactin/CTTN$369,492
P01 · FY2024 · HL · contact PI
Role of Endothelial eNAMPT/NAMPT secretion and TLR4 signaling in the ARDS Vascular Endotype$297,844
P01 · FY2024 · HL · contact PI
Administrative Core$153,742
P01 · FY2024 · HL · contact PI
Cytoskeletal Regulation of Lung Endothelial Pathobiology in ARDS$2,185,600
P01 · FY2023 · HL · contact PI
A Randomized Phase 2A Clinical Trial Pioneering the Utility of an eNAMPT-Reducing Therapy in ARDS/VILI: the PUERTA Trial$1,500,000
R44 · FY2023 · HL · contact PI
Targeting the eNAMPT/TLR4 pathway to reduce Inflammatory Bowel Disease severity$975,215
R42 · FY2023 · DK · contact PI
Preclinical Development of a Novel eNAMPT-Neutralizing mAb for Pulmonary Hypertension$809,000
R42 · FY2023 · HL · contact PI
Regulation of Peripheral EC Cytoskeletal Remodeling, Gap Closure and Barrier Restoration by nmMLCK/MYLK and Cortactin/CTTN$402,038
P01 · FY2023 · HL · contact PI
Role of Endothelial eNAMPT/NAMPT secretion and TLR4 signaling in the ARDS Vascular Endotype$328,954
P01 · FY2023 · HL · contact PI
Administrative Core$168,850
P01 · FY2023 · HL · contact PI
Validation of a Genetic-based Biomarker Panel for Stratification of Mortality Risk in ARDS Patients$115,125
R21 · FY2023 · HL
Cytoskeletal Regulation of Lung Endothelial Pathobiology in ARDS$2,139,356
P01 · FY2022 · HL · contact PI
eNamptorTM: A Humanized mAb To Reduce the Severity of Radiation Pneumonitis and Fibrosis$1,000,000
R42 · FY2022 · HL · contact PI
ARIZONA PRIDE-25: TRANSLATIONAL APPROACHES TO HEALTH DISPARITIES IN THE LUNG$457,302
R25 · FY2022 · HL · contact PI
Regulation of Peripheral EC Cytoskeletal Remodeling, Gap Closure and Barrier Restoration by nmMLCK/MYLK and Cortactin/CTTN$417,085
P01 · FY2022 · HL · contact PI
Novel Involvement of NAMPT and TLR4 in PAH Vascular Remodeling$296,500
R01 · FY2022 · HL · contact PI
Targeting the eNAMPT/TLR4 pathway to reduce Inflammatory Bowel Disease severity$269,233
R42 · FY2022 · DK · contact PI
Preclinical Development of a Novel eNAMPT-Neutralizing mAb for Pulmonary Hypertension$259,613
R42 · FY2022 · HL · contact PI
Role of Endothelial eNAMPT Secretion and TLR4 Signaling in the ARDS Vascular Endotype$232,675
R01 · FY2022 · HL · contact PI
Administrative Core$170,522
P01 · FY2022 · HL · contact PI
Novel Involvement of NAMPT and TLR4 in PAH Vascular Remodeling$164,000
R01 · FY2022 · HL · contact PI
Role of Endothelial eNAMPT/NAMPT secretion and TLR4 signaling in the ARDS Vascular Endotype$97,951
P01 · FY2022 · HL · contact PI
eNamptorTM: A Humanized mAb To Reduce the Severity of Radiation Pneumonitis and Fibrosis$1,000,000
R42 · FY2021 · HL · contact PI
Novel Therapeutic Antibody Targeting of Extracellular NAMPT in Ventilator-Induced Lung Injury (VILI)$750,000
R42 · FY2021 · HL · contact PI
Novel Involvement of NAMPT and TLR4 in PAH Vascular Remodeling$460,500
R01 · FY2021 · HL · contact PI
Critical Role of NAMPT and Toll-Like Receptor 4 in Inflammation and Mechanical Ventilator-Induced Lung Injury (VILI)$459,929
P01 · FY2021 · HL · contact PI
ARIZONA PRIDE-25: TRANSLATIONAL APPROACHES TO HEALTH DISPARITIES IN THE LUNG$457,305
R25 · FY2021 · HL · contact PI
Molecular Biology and Genetics Core$227,178
P01 · FY2021 · HL · contact PI
Cytoskeletal Regulation of Lung Endothelial Pathobiology$2,335,732
P01 · FY2020 · HL · contact PI
Novel Therapeutic Antibody Targeting of Extracellular NAMPT in Ventilator-Induced Lung Injury (VILI)$750,000
R42 · FY2020 · HL · contact PI
Critical Role of NAMPT and Toll-Like Receptor 4 in Inflammation and Mechanical Ventilator-Induced Lung Injury (VILI)$511,032
P01 · FY2020 · HL · contact PI
Novel Involvement of NAMPT and TLR4 in PAH Vascular Remodeling$460,500
R01 · FY2020 · HL · contact PI
ARIZONA PRIDE-25: TRANSLATIONAL APPROACHES TO HEALTH DISPARITIES IN THE LUNG$457,122
R25 · FY2020 · HL · contact PI
Structure-Function Analysis of nmMLCK in EC Barrier Responses$437,361
P01 · FY2020 · HL · contact PI
eNamptorTM: A Humanized mAb To Reduce the Severity of Radiation Pneumonitis and Fibrosis$300,001
R42 · FY2020 · HL · contact PI
Extracellular NAMPT is a Novel Therapeutic Target in Chorioamnionitis-Related Prematurity (ChorP)$265,096
R41 · FY2020 · HD · contact PI
Molecular Biology and Genetics Core$252,420
P01 · FY2020 · HL · contact PI
Administrative Core$120,489
P01 · FY2020 · HL · contact PI
Cytoskeletal Regulation of Lung Endothelial Pathobiology$2,335,732
P01 · FY2019 · HL · contact PI
Critical Role of NAMPT and Toll-Like Receptor 4 in Inflammation and Mechanical Ventilator-Induced Lung Injury (VILI)$511,032
P01 · FY2019 · HL · contact PI
ARIZONA PRIDE-25: TRANSLATIONAL APPROACHES TO HEALTH DISPARITIES IN THE LUNG$465,043
R25 · FY2019 · HL · contact PI
Novel Involvement of NAMPT and TLR4 in PAH Vascular Remodeling$460,500
R01 · FY2019 · HL · contact PI
Structure-Function Analysis of nmMLCK in EC Barrier Responses$437,361
P01 · FY2019 · HL · contact PI
Molecular Biology and Genetics Core$252,420
P01 · FY2019 · HL · contact PI
Novel Therapeutic Antibody Targeting of Extracellular NAMPT in Ventilator-Induced Lung Injury (VILI)$225,000
R42 · FY2019 · HL · contact PI
The CRIT-ICU Biomarker Panel for Stratification of Mortality Risk in ARDS Patients$225,000
R41 · FY2019 · HL · contact PI
Administrative Core$120,489
P01 · FY2019 · HL · contact PI
ARIZONA PRIDE-25: TRANSLATIONAL APPROACHES TO HEALTH DISPARITIES IN THE LUNG$107,994
R25 · FY2019 · HL · contact PI
Cytoskeletal Regulation of Lung Endothelial Pathobiology$2,336,280
P01 · FY2018 · HL · contact PI
Critical Role of NAMPT and Toll-Like Receptor 4 in Inflammation and Mechanical Ventilator-Induced Lung Injury (VILI)$511,032
P01 · FY2018 · HL · contact PI
Structure-Function Analysis of nmMLCK in EC Barrier Responses$428,613
P01 · FY2018 · HL · contact PI
nmMLCK Contributes to Genetic and Environmental Asthma Susceptibility$365,497
R01 · FY2018 · HL · contact PI
Phenomic and genomic study to subphenotype Hispanics with pulmonary hypertension$307,000
U01 · FY2018 · HL
Molecular Biology and Genetics Core$252,420
P01 · FY2018 · HL · contact PI
Novel Targeting of the S1P Receptor, S1P1, and Nox4 as Therapeutic Approaches in ARDS$224,984
R41 · FY2018 · HL · contact PI
Administrative Core$118,082
P01 · FY2018 · HL · contact PI
Cytoskeletal Regulation of Lung Endothelial Pathobiology$2,338,457
P01 · FY2017 · HL · contact PI
Structure-Function Analysis of nmMLCK in EC Barrier Responses$437,361
P01 · FY2017 · HL · contact PI
nmMLCK Contributes to Genetic and Environmental Asthma Susceptibility$365,497
R01 · FY2017 · HL · contact PI
ARIZONA PRIDE-25: ADVANCED HEALTH DISPARITIES TRAINING PROGRAM IN HEART, LUNG, BLOOD, AND SLEEP CONDITIONS$344,769
R25 · FY2017 · HL · contact PI
Administrative Core$120,489
P01 · FY2017 · HL · contact PI
Cytoskeletal Regulation of Lung Endothelial Pathobiology$2,110,784
P01 · FY2016 · HL · contact PI
nmMLCK Contributes to Genetic and Environmental Asthma Susceptibility$420,126
R01 · FY2016 · HL · contact PI
ARIZONA PRIDE-25: ADVANCED HEALTH DISPARITIES TRAINING PROGRAM IN HEART, LUNG, BLOOD, AND SLEEP CONDITIONS$355,761
R25 · FY2016 · HL · contact PI
Regulation of nonmuscle myosin light chain kinase structure and function of ARDS$262,106
R01 · FY2016 · HL · contact PI
Structure-Function Analysis of nmMLCK in EC Barrier Responses$201,789
P01 · FY2016 · HL · contact PI
Administrative Core$120,456
P01 · FY2016 · HL · contact PI
nmMLCK Contributes to Genetic and Environmental Asthma Susceptibility$422,261
R01 · FY2015 · HL · contact PI
ARIZONA PRIDE-25: ADVANCED HEALTH DISPARITIES TRAINING PROGRAM IN HEART, LUNG, BLOOD, AND SLEEP CONDITIONS$341,534
R25 · FY2015 · HL · contact PI
ARIZONA PRIDE-25: ADVANCED HEALTH DISPARITIES TRAINING PROGRAM IN HEART, LUNG, BLOOD, AND SLEEP CONDITIONS$289,903
R25 · FY2014 · HL · contact PI
Phase II Study of Inhales Carbon Monoxide for the Treatment of Idiopathic Pulmona$181,532
U01 · FY2014 · HL
Genomic Phenotyping and Mechanisms in sarcoidosis and AAT$152,391
U01 · FY2014 · HL
Phase II Study of Inhales Carbon Monoxide for the Treatment of Idiopathic Pulmona$1,766,543
U01 · FY2013 · HL
Genomic Phenotyping and Mechanisms in sarcoidosis and AAT$148,036
U01 · FY2013 · HL
Cytoskeletal Regulation of Lung Endothelial Pathobiology$2,405,143
P01 · FY2012 · HL · contact PI
Phase II Study of Inhales Carbon Monoxide for the Treatment of Idiopathic Pulmona$1,900,200
U01 · FY2012 · HL
Pathogenic Mechanisms of PBEF in Ventilator Induced Lung Injury$396,290
R01 · FY2012 · HL · contact PI
Regulation of Lung Barrier Function by Endothelial Cell (EC) MLCK$300,649
P01 · FY2012 · HL · contact PI
Administrative Core$300,642
P01 · FY2012 · HL · contact PI
Genomic Phenotyping and Mechanisms in sarcoidosis and AAT$169,125
U01 · FY2012 · HL
Translational Approaches to Reducing Health Disparities in Lung Disease$25,000
R13 · FY2012 · HL · contact PI
Cytoskeletal Regulation of Lung Endothelial Pathobiology$2,405,143
P01 · FY2011 · HL · contact PI
Pathogenic Mechanisms of PBEF in Ventilator Induced Lung Injury$400,015
R01 · FY2011 · HL · contact PI
Regulation of Asthmatic Inflammation by Non-Muscle MLCK$395,068
R01 · FY2011 · HL · contact PI
Differntial Role of S1P Receptors in Inflammatory Lung Injury$392,499
P01 · FY2011 · HL · contact PI
Regulation of Lung Barrier Function by Endothelial Cell (EC) MLCK$300,649
P01 · FY2011 · HL · contact PI
Administrative Core$300,642
P01 · FY2011 · HL · contact PI
Cytoskeletal Regulation of Lung Endothelial Pathobiology$2,405,143
P01 · FY2010 · HL · contact PI
Phase II Study of Inhales Carbon Monoxide for the Treatment of Idiopathic Pulmona$1,359,804
U01 · FY2010 · HL
Regulation of Lung Barrier Function by Endothelial Cell (EC) MLCK$410,390
P01 · FY2010 · HL · contact PI
Regulation of Asthmatic Inflammation by Non-Muscle MLCK$409,134
R01 · FY2010 · HL · contact PI
Pathogenic Mechanisms of PBEF in Ventilator Induced Lung Injury$408,335
R01 · FY2010 · HL · contact PI
Administrative Core$80,374
P01 · FY2010 · HL · contact PI
Cytoskeletal Regulation of Lung Endothelial Pathobiology$2,351,525
P01 · FY2009 · HL · contact PI
Pathogenic Mechanisms of PBEF in Ventilator Induced Lung Injury$402,706
R01 · FY2009 · HL · contact PI
Regulation of Lung Barrier Function by Endothelial Cell (EC) MLCK$401,241
P01 · FY2009 · HL · contact PI
Regulation of Asthmatic Inflammation by Non-Muscle MLCK$392,207
R01 · FY2009 · HL · contact PI
Administrative Core$78,581
P01 · FY2009 · HL · contact PI
Cytoskeletal Regulation of Lung Endothelial Pathobiology$2,399,985
P01 · FY2008 · HL · contact PI
Regulation of Lung Barrier Function by Endothelial Cell (EC) MLCK$409,516
P01 · FY2008 · HL · contact PI
Regulation of Asthmatic Inflammation by Non-Muscle MLCK$406,201
R01 · FY2008 · HL · contact PI
Regulation of Lung Barrier Function by Endothelial Cell (EC) Myosin Light Chain K$164,217
R01 · FY2008 · HL · contact PI
Administrative Core$80,191
P01 · FY2008 · HL · contact PI
CYTOSKELETAL REGULATION OF LUNG ENDOTHELIAL PATHOBIOLOGY$2,276,258
P01 · FY2007 · HL · contact PI
Novel therapies for VALI-induced edema$476,328
P50 · FY2007 · HL · contact PI
Regulation of lung pathobiology by endothelial cell MLCK$446,226
P01 · FY2007 · HL · contact PI
Endothelial cytoskeletal responses to platelet phospholipids$441,717
P01 · FY2007 · HL · contact PI
CYTOSKELETAL REGULATION OF LUNG ENDOTHELIAL PATHOBIOLOGY$2,290,928
P01 · FY2006 · HL · contact PI
Regulation of lung pathobiology by endothelial cell MLCK$231,925
P01 · FY2006 · HL · contact PI
Endothelial cytoskeletal responses to platelet phospholipids$229,583
P01 · FY2006 · HL · contact PI
Endothelial Cell Phenotypes in Health and Disease$14,000
R13 · FY2006 · HL · contact PI
CYTOSKELETAL REGULATION OF LUNG ENDOTHELIAL PATHOBIOLOGY$1,236,268
P01 · FY2005 · HL
CYTOSKELETAL REGULATION OF LUNG ENDOTHELIAL PATHOBIOLOGY$1,099,271
P01 · FY2005 · HL
VENTILATOR ASSOCIATED LUNG INJURY: MOLECULAR APPROACHES$4,107,124
P50 · FY2004 · HL
CYTOSKELETAL REGULATION OF LUNG ENDOTHELIAL PATHOBIOLOGY$2,307,153
P01 · FY2004 · HL
SCIENTIFIC REVIEW AND EVALUATION GRANT$600,000
U09 · FY2004 · HL
APPLIED GENOMICS IN CARDIOPULMONARY DISEASE$100,000
U01 · FY2004 · HL
SHORT-TERM TRAINING FOR MINORITY STUDENTS$94,521
T35 · FY2004 · HL
VENTILATOR ASSOCIATED LUNG INJURY: MOLECULAR APPROACHES$4,083,278
P50 · FY2003 · HL
CYTOSKELETAL REGULATION OF LUNG ENDOTHELIAL PATHOBIOLOGY$2,275,106
P01 · FY2003 · HL
SCIENTIFIC REVIEW AND EVALUATION GRANT$1,780,000
U09 · FY2003 · HL
Multidisciplinary Training Program in Lung Diseases$1,103,798
T32 · FY2003 · HL
Novel therapies for VALI-induced edema$228,376
P50 · FY2003 · HL
SHORT-TERM TRAINING FOR MINORITY STUDENTS$132,149
T35 · FY2003 · HL
Core A- Administrative Core$75,658
P50 · FY2003 · HL
MOLECULAR REGULATION OF ENDOTHELIAL CELL PERMEABILITY$1,497,971
P01 · FY2002 · HL
Multidisciplinary Training Program in Lung Diseases$1,058,267
T32 · FY2002 · HL
LUNG VASCULAR BARRIER PRESERVATION BY PLATELET PRODUCTS$367,875
R01 · FY2002 · HL
APPLIED GENOMICS IN CARDIOPULMONARY DISEASE$362,144
U01 · FY2002 · HL
REGULATION OF ENDOTHELIAL CELL CONTRACTION$197,422
P01 · FY2002 · HL
REGULATION OF LUNG ENDOTHELIAL CONTRACTION/PERMEABILITY$190,939
R01 · FY2002 · HL
MOLECULAR REGULATION OF ENDOTHELIAL CELL PERMEABILITY$1,454,340
P01 · FY2001 · HL
MULTIDISCIPLINARY TRAINING PROGRAM IN LUNG DISEASES$633,588
T32 · FY2001 · HL
APPLIED GENOMICS IN CARDIOPULMONARY DISEASE$348,101
U01 · FY2001 · HL
REGULATION OF LUNG ENDOTHELIAL CONTRACTION/PERMEABILITY$279,744
R01 · FY2001 · HL
PROTEIN PHOSPHATASES IN ENDOTHELIAL CELL PERMEABILITY$260,629
R01 · FY2001 · HL
REGULATION OF ENDOTHELIAL CELL CONTRACTION$197,422
P01 · FY2001 · HL
SHORT-TERM TRAINING FOR MINORITY STUDENTS$122,580
T35 · FY2001 · HL
MOLECULAR REGULATION OF ENDOTHELIAL CELL PERMEABILITY$1,415,608
P01 · FY2000 · HL
APPLIED GENOMICS IN CARDIOPULMONARY DISEASE$338,880
U01 · FY2000 · HL
REGULATION OF LUNG ENDOTHELIAL CONTRACTION/PERMEABILITY$273,896
R01 · FY2000 · HL
PROTEIN PHOSPHATASES IN ENDOTHELIAL CELL PERMEABILITY$253,038
R01 · FY2000 · HL
REGULATION OF ENDOTHELIAL CELL CONTRACTION$229,735
P01 · FY2000 · HL
SHORT-TERM TRAINING FOR MINORITY STUDENTS$114,804
T35 · FY2000 · HL